Mary E.D. Flowers

Research interests

Publications

• EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

  Bone Marrow Transplantation · 2018 · 10.1038/s41409-018-0204-7

• Ibrutinib for chronic graft-versus-host disease after failure of prior therapy

  Blood · 2017 · 10.1182/blood-2017-07-793786

• Cord-Blood Transplantation in Patients with Minimal Residual Disease

  New England Journal of Medicine · 2016 · 10.1056/nejmoa1602074

• Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

  Transplantation and Cellular Therapy · 2015 · 10.1016/j.bbmt.2015.02.025

• Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

  Transplantation and Cellular Therapy · 2014 · 10.1016/j.bbmt.2014.10.021

• How we treat chronic graft-versus-host disease

  Blood · 2014 · 10.1182/blood-2014-08-551994

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

  Transplantation and Cellular Therapy · 2014 · https://doi.org/10.1016/j.bbmt.2014.12.001

• Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

  Blood · 2011 · https://doi.org/10.1182/blood-2010-08-302109

• Risk factors for acute GVHD and survival after hematopoietic cell transplantation

  Blood · 2011 · 10.1182/blood-2011-06-364265

• Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.25.6693

• Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

  Blood · 2009 · 10.1182/blood-2008-09-178046

• HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

  Transplantation and Cellular Therapy · 2008 · https://doi.org/10.1016/j.bbmt.2008.03.005

• Solid cancers after allogeneic hematopoietic cell transplantation

  Blood · 2008 · 10.1182/blood-2008-05-158782

• Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report

  Transplantation and Cellular Therapy · 2006 · 10.1016/j.bbmt.2005.10.023

• Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

  Transplantation and Cellular Therapy · 2006 · 10.1016/j.bbmt.2006.01.008

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

  Transplantation and Cellular Therapy · 2005 · https://doi.org/10.1016/j.bbmt.2005.09.004

• Chronic graft-versus-host disease

  Transplantation and Cellular Therapy · 2003 · https://doi.org/10.1053/bbmt.2003.50026

• Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

  Blood · 2003 · 10.1182/blood-2002-08-2628

• Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

  Blood · 2002 · 10.1182/blood-2002-03-0993

• Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

  Blood · 2002 · 10.1182/blood-2002-01-0011

• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

  Blood · 2001 · https://doi.org/10.1182/blood.v97.11.3390

• Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

  Blood · 2001 · 10.1182/blood.v97.11.3380

• Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers

  New England Journal of Medicine · 2001 · https://doi.org/10.1056/nejm200101183440303

• Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial

  Blood · 2000 · 10.1182/blood.v96.6.2055

• Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

  PubMed · 1991

Current projects

No projects listed.